tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AU:SNT Stock Latest News

Syntara Highlights Risks and Uncertainty Around Forward-Looking Statements
Company AnnouncementsSyntara Highlights Risks and Uncertainty Around Forward-Looking Statements
14d ago
Syntara Cautions Investors on Risks in Forward-Looking Statements
PremiumCompany Announcements
Syntara Cautions Investors on Risks in Forward-Looking Statements
16d ago
Syntara Seeks ASX Quotation for 634,110 Additional Shares
PremiumCompany Announcements
Syntara Seeks ASX Quotation for 634,110 Additional Shares
17d ago
Syntara Sets Investor Webinar Ahead of Pivotal 2026 Clinical Readouts
PremiumCompany Announcements
Syntara Sets Investor Webinar Ahead of Pivotal 2026 Clinical Readouts
21d ago
Syntara Targets Pivotal 2026 as Lead Cancer Drug and Pipeline Advance
PremiumCompany Announcements
Syntara Targets Pivotal 2026 as Lead Cancer Drug and Pipeline Advance
21d ago
Syntara’s Amsulostat to Join MRFF-Funded Pancreatic Cancer Trials as Non-Dilutive Backing Tops A$10m
PremiumCompany AnnouncementsSyntara’s Amsulostat to Join MRFF-Funded Pancreatic Cancer Trials as Non-Dilutive Backing Tops A$10m
29d ago
Syntara Names CFO Tim Luscombe as New Company Secretary
Premium
Company Announcements
Syntara Names CFO Tim Luscombe as New Company Secretary
1M ago
Syntara Completes Phase 2 Recruitment for Neuroinflammation Drug in High-Risk Sleep Disorder
Premium
Company Announcements
Syntara Completes Phase 2 Recruitment for Neuroinflammation Drug in High-Risk Sleep Disorder
1M ago
Syntara Positions for Transformational 2026 as Multiple Clinical Programs Near Key Readouts
PremiumCompany Announcements
Syntara Positions for Transformational 2026 as Multiple Clinical Programs Near Key Readouts
2M ago
Syntara Limited Showcases Promising Amsulostat Data at ASH Meeting
PremiumCompany Announcements
Syntara Limited Showcases Promising Amsulostat Data at ASH Meeting
3M ago
Syntara Limited Highlights Uncertainty in Future Projections
PremiumCompany Announcements
Syntara Limited Highlights Uncertainty in Future Projections
3M ago
Syntara Limited Announces Director’s Interest Change
PremiumCompany Announcements
Syntara Limited Announces Director’s Interest Change
3M ago
Syntara Limited Announces Director’s Increased Share Options
PremiumCompany AnnouncementsSyntara Limited Announces Director’s Increased Share Options
3M ago
Syntara Limited Issues New Performance Rights
Premium
Company Announcements
Syntara Limited Issues New Performance Rights
3M ago
Syntara Limited Issues Performance Rights Under Employee Incentive Scheme
Premium
Company Announcements
Syntara Limited Issues Performance Rights Under Employee Incentive Scheme
3M ago
Syntara Advances SNT-9465 in Clinical Trials for Skin Scarring Treatment
PremiumCompany Announcements
Syntara Advances SNT-9465 in Clinical Trials for Skin Scarring Treatment
3M ago
Syntara Limited Hosts Webinar on Skin Scarring Treatment and Drug Development
PremiumCompany Announcements
Syntara Limited Hosts Webinar on Skin Scarring Treatment and Drug Development
3M ago
Syntara Limited Launches Phase 2 Trial for MDS Treatment in Australia
PremiumCompany Announcements
Syntara Limited Launches Phase 2 Trial for MDS Treatment in Australia
3M ago
Syntara Limited AGM: Key Resolutions Passed, One Withdrawn
PremiumCompany Announcements
Syntara Limited AGM: Key Resolutions Passed, One Withdrawn
3M ago
Syntara Limited Highlights Leadership Expertise at Annual General Meeting
PremiumCompany AnnouncementsSyntara Limited Highlights Leadership Expertise at Annual General Meeting
3M ago
Syntara Limited Advances Clinical Programs with Promising Results and Strong Financial Position
Premium
Company Announcements
Syntara Limited Advances Clinical Programs with Promising Results and Strong Financial Position
3M ago
Syntara Limited Gains EU Orphan Drug Designation for Amsulostat
Premium
Company Announcements
Syntara Limited Gains EU Orphan Drug Designation for Amsulostat
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >